ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750039 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750039; 2) Community: the network communities that were significantly associated with the response to NSC 750039; 3) Molecule: the relationships between components within communities and NSC 750039; 4) MDR: the compounds that were significantly associated with the NSC 750039.

NSC Compound Enrichment Correlation
NSC 639741 Null 0.0284045326811616 0.14965398
NSC 641172 Null 0.0284045326811616 0.11369113
NSC 647117 Null 0.0284045326811616 0.29755012
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.0284045326811616 0.11420708
NSC 670313 Null 0.0284045326811616 0.4135701
NSC 670765 Null 0.0284045326811616 0.028641654
NSC 676372 Null 0.0284045326811616 0.32097848
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0284045326811616 0.074574407
NSC 679800 Null 0.0284045326811616 0.29304035
NSC 681645 Camptothecin Derivative 0.0284045326811616 0.10870262
Total:102  Current:64    [First] [Prev] [Next] [Last]